Skip to Main Content

Author Details

Colin P Dinney
The University of Texas MD Anderson Cancer Center
1990
442
83
PMIDPaper TitleJournal TitlePublished Year
37442564Impact of age >70⿿years on oncological outcomes in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guérin.BJU Int2024
37922370Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center Experience.J Urol2024
36250944Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not Therapeutic.J Urol2023
37558542Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy.Eur Urol Oncol2023
37662238Combined Mek inhibition and <i>Pparg</i> activation Eradicates Muscle Invasive Bladder cancer in a Mouse Model of BBN-induced Carcinogenesis.bioRxiv2023
37705979Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval.Front Immunol2023
37851909The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomy.Can Urol Assoc J2023
37833193Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract.Eur Urol Oncol2023
37055873The current status of gene therapy in bladder cancer.Expert Rev Anticancer Ther2023
37314813Stage-dependent survival in patients treated with neoadjuvant chemotherapy and radical cystectomy.Minerva Urol Nephrol2023
37211780Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply.J Urol2023
37246493Bacillus Calmette-Guérin (BCG) unresponsive non-muscle-invasive bladder cancer: are the subgroups equal?BJU Int2023
37441349Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes.Eur Urol Open Sci2023
37468392Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer.Eur Urol Oncol2023
36404232Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship.Urol Oncol2023
36795962Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort.J Urol2023
33935020Implications of Guideline-based, Risk-stratified Restaging Transurethral Resection of High-grade Ta Urothelial Carcinoma on Bacillus Calmette-Guérin Therapy Outcomes.Eur Urol Oncol2022
35847448Lentiviral interferon: A novel method for gene therapy in bladder cancer.Mol Ther Oncolytics2022
35770498All High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Guérin Response in High-Grade Ta Tumors.J Urol2022
35770497Reply by Authors.J Urol2022
35811851Erratum: The origin of bladder cancer from mucosal field effects.iScience2022
35961847Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma.Urol Oncol2022
36169695Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.World J Urol2022
34920986Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin.Eur Urol Oncol2022
34854189Should patients with non-muscle-invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette-Guérin?BJU Int2022
35039231Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma.Clin Genitourin Cancer2022
35181282Corrigendum to "Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium" [Eur Urol Focus 2021;7:1347-54].Eur Urol Focus2022
34933753Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial.Eur Urol2022
34694143Role of Lymphadenectomy during Radical Cystectomy for Nonmuscle-Invasive Bladder Cancer: Results from a Multi-Institutional Experience.J Urol2022
34847263Reduced-dose bacillus Calmette-Guérin (BCG) in an era of BCG shortage: real-world experience from a tertiary cancer centre.BJU Int2022
32981193Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.BJU Int2021
35475152Multimodal kidney-preserving approach in localised and locally advanced high-risk upper tract urothelial carcinoma.BJUI Compass2021
33881933Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma.J Urol2021
33484074Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer.BJU Int2021
33872050Contemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy.J Urol2021
33734859Reply by Authors.J Urol2021
33619985Oncologic Equipoise Between Robotic and Open Radical Cystectomy.J Endourol2021
33783950Time interval from transurethral resection of bladder tumour to bacille Calmette-Guérin induction does not impact therapeutic response.BJU Int2021
33563539Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project.Urol Oncol2021
34514028Unique somatic variants in DNA from urine exosomes of individuals with bladder cancer.Mol Ther Methods Clin Dev2021
34186127What Women Want: Radical Cystectomy and Perioperative Sexual Function Educational Needs.Urology2021
34184926Progression of Disease after Bacillus Calmette-Guérin Therapy: Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy.J Urol2021
34117914Impact of sex on response to BCG in non-muscle invasive bladder cancer patients: a contemporary review from a tertiary care center.World J Urol2021
34370078Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer.World J Urol2021
34195319Revisiting an Old Conundrum: A Systematic Review and Meta-Analysis of Intravesical Therapy for Treatment of Urothelial Carcinoma of the Prostate.Bladder Cancer2021
34372685Reply by Authors.J Urol2021
33253641Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.Lancet Oncol2021
33308972Utilizing time-driven activity-based costing to determine open radical cystectomy and ileal conduit surgical episode cost drivers.Urol Oncol2021
33158662Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer.Eur Urol2021
33210440The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin.BJU Int2021
  • 1 - 50 of 442

Recommended Authors

Saum Ghodoussipour
Rutgers Cancer Institute of New Jersey
Career Start Year 2016
Number of shared co-authors 1
Stephanie A Wankowicz
University of California San Francisco
Career Start Year 2014
Number of shared co-authors 1
Parminder Singh
Mayo Clinic
Career Start Year 2013
Number of shared co-authors 3
Izak Faiena
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 3
Alexandra Drakaki
David Geffen School of Medicine at university of california los angeles
Career Start Year 2009
Number of shared co-authors 9
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Career Start Year 2008
Number of shared co-authors 20
Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
Career Start Year 2007
Number of shared co-authors 4
Bishoy M Faltas
Sandra and Edward Meyer Cancer Center
Career Start Year 2007
Number of shared co-authors 8
Michelle R Downes
University of Toronto
Career Start Year 2006
Number of shared co-authors 6
Amirali Salmasi
University of California San Diego
Career Start Year 2005
Number of shared co-authors 2
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Career Start Year 2004
Number of shared co-authors 13
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 1
Syed A Hussain
University of Sheffield and Sheffield Teaching Hospitals
Career Start Year 2001
Number of shared co-authors 5
Cheol Kwak
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2000
Number of shared co-authors 0
H??l??ne Hovington
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1999
Number of shared co-authors 8
J??rn Kamradt
Clinic of Urology and Pediatric Urology, University of Saarland
Career Start Year 1996
Number of shared co-authors 1
Feliksas Jankevicius
Clinic of Gastroenterology, Vilnius University
Career Start Year 1995
Number of shared co-authors 2
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 8
Louis Lacombe
CHU de Quebec-Universite Laval
Career Start Year 1994
Number of shared co-authors 12
David I Quinn
USC Norris Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 11
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 0
Alain Bergeron
Centre de recherche sur le cancer de l'Universite Laval
Career Start Year 1990
Number of shared co-authors 8
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 12
Arnulf Stenzl
Eberhard Karls University of Tubingen
Career Start Year 1984
Number of shared co-authors 16
Eric A Klein
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 53
David E Neal
University of Oxford, John Radcliffe Hospital
Career Start Year 1981
Number of shared co-authors 49
Hendrik Van Poppel
University Hospitals Leuven
Career Start Year 1981
Number of shared co-authors 15
Cora N Sternberg
Meyer Cancer Center, Englander Institute for Precision Medicine
Career Start Year 1978
Number of shared co-authors 15
Timothy L Ratliff
Purdue University
Career Start Year 1978
Number of shared co-authors 2
Hartwig Huland
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Career Start Year 1971
Number of shared co-authors 10

Collaborators

Herbert Barton Grossman
University of Texas MD Anderson Cancer Center
Co-authored papers 113
David J McConkey
Johns Hopkins School of Medicine
Co-authored papers 75
Bogdan Czerniak
University of Texas MD Anderson Cancer Center
Co-authored papers 62
Surena F Matin
The University of Texas MD Anderson Cancer Center
Co-authored papers 30
Philippe E Spiess
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 25
Jolanta Bondaruk
The University of Texas MD Anderson Cancer Center
Co-authored papers 18
Liana Adam
The University of Texas MD Anderson Cancer Center
Co-authored papers 18
Menashe Bar-Eli
The University of Texas MD Anderson Cancer Center
Co-authored papers 17
Yves Fradet
CHU de Quebec-Universite Laval
Co-authored papers 15
Derya Tilki
Universitatsklinikum Hamburg-Eppendorf
Co-authored papers 14
Yu Shen
Co-authored papers 12
Jonathan L Wright
University of Washington Medical Center
Co-authored papers 12
Todd M Morgan
University of Michigan ann arbor
Co-authored papers 10
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Co-authored papers 10
Evan Y Yu
University of Washington and Fred Hutchinson Cancer Research Center
Co-authored papers 9
N??ria Malats
Spanish National Cancer Research Centre
Co-authored papers 8
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 8
Gerald L Andriole
Co-authored papers 7
John N Weinstein
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Alan Pollack
University of Miami Miller School of Medicine
Co-authored papers 7
David Cogdell
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Qingyi Wei
South China University of Technology
Co-authored papers 6
Montserrat Garcia-Closas
National Cancer Institute
Co-authored papers 6
Margaret R Karagas
Co-authored papers 6
David J Hunter
The Kolling Institute, University of Sydney, and Royal North Shore Hospital
Co-authored papers 6
Zhaoming Wang
St Jude Children's Research Hospital
Co-authored papers 6
Jonine D Figueroa
The Usher Institute, The University of Edinburgh
Co-authored papers 6
Demetrius Albanes
Co-authored papers 6
Lambertus A Kiemeney
Co-authored papers 5
Lance C Pagliaro
Mayo Clinic
Co-authored papers 5
Release 1.2